Categories
Change Password!
Reset Password!
Short-term nimesulide use demonstrates good tolera...
Effectiveness of PCAB vs. high-dose PPI in refract...
Gastroesophageal reflux disease (GERD) is a chronic ailment marked by the reflux of gastric contents into the esophagus, resulting in persistent...
Taking NSAIDs after 60? Study warns of increased G...
A large hospital-based study from Beijing has identified significant risk factors associated with nonsteroidal anti-inflammatory drug (NSAID)-ind...
Semaglutide shows significant fibrosis improvement...
Metabolic dysfunction associated steatohepatitis (MASH) continues to accelerate fibrosis progression within metabolic dysfunction associated stea...
Rabeprazole emerges as preferred PPI for GERD pati...
Tackling gastroesophageal reflux disease (GERD) in patients with multiple comorbidities and concurrent medications remains a clinical challenge,...
Tegoprazan emerges as fast-acting alternative to P...
A large study has positioned tegoprazan, a potassium-competitive acid blocker (PCAB), as a next-generation therapy for gastroesophageal reflux di...
Low-dose aspirin raises gastric and duodenal ulcer...
A large population-based analysis of over 220,000 volunteers has revealed that low-dose aspirin initiation is connected with increased risk of ga...
Long-term intramuscular cyanocobalamin therapy in...
Corpus atrophic gastritis (CAG) is a chronic autoimmune condition characterized by progressive loss of gastric acid secretion and intrinsic facto...
Corticosteroids cut acute kidney injury risk in se...
A new analysis of patients with severe alcohol-associated hepatitis suggests that corticosteroid therapy may noticeably minimize the risk of deve...
High-dose vs. conventional therapy for H. pylori e...
Optimizing Helicobacter pylori (H. pylori) eradication therapy is fundamental in the era of rising antibiotic resistance.
